We have set up an assay to study the interactions of live pathogens with their hosts by using protein and glycosaminoglycan arrays probed by surface plasmon resonance imaging. We have used this assay to characterize the interactions of Leishmania promastigotes with ϳ70 mammalian host biomolecules (extracellular proteins, glycosaminoglycans, growth factors, cell surface receptors). We have identified, in total, 27 new partners (23 proteins, 4 glycosaminoglycans) of procyclic promastigotes of six Leishmania species and 18 partners (15 proteins, 3 glycosaminoglycans) of three species of stationary-phase promastigotes for all the strains tested. The diversity of the interaction repertoires of Leishmania parasites reflects their dynamic and complex interplay with their mammalian hosts, which depends mostly on the species and strains of Leishmania. Stationary-phase Leishmania parasites target extracellular matrix proteins and glycosaminoglycans, which are highly connected in the extracellular interaction network. Heparin and heparan sulfate bind to most Leishmania strains tested, and 6-O-sulfate groups play a crucial role in these interactions. Numerous Leishmania strains bind to tropoelastin, and some strains are even able to degrade it. Several strains interact with collagen VI, which is expressed by macrophages. Most Leishmania promastigotes interact with several regulators of angiogenesis, including antiangiogenic factors (endostatin, anastellin) and proangiogenic factors (ECM-1, VEGF, and TEM8 [also known as anthrax toxin receptor 1]), which are regulated by hypoxia. Since hypoxia modulates the infection of macrophages by the parasites, these interactions might influence the infection of host cells by Leishmania.
L
eishmaniasis is caused by parasitic protozoa of the genus Leishmania, which infect humans via the bite of phlebotomine sand flies. There are three major forms of the disease: cutaneous, mucocutaneous, and visceral. About 12 million individuals are infected worldwide with 2 million new infections each year (1) . The genus Leishmania has two morphological forms in the vertebrate host, intracellular amastigotes and flagellate extracellular promastigotes, which represent the infectious stage and are injected into the host skin. Promastigotes develop from the procyclic stage to the highly virulent metacyclic stage within the sand fly vector and are inoculated into hemorrhagic pools in the skin. Blood is involved in transmission, and promastigotes interact with leukocytes (2, 3) . Most studies of host-Leishmania interactions have thus focused on the interaction of Leishmania promastigotes with their cellular targets (dermal dendritic cells, mast cells, and macrophages) (4) . Alternatively, promastigotes are deposited into the extracellular matrix (ECM) of the dermis in a bloodless context, with no apparent blood uptake by the vector (3) . In this case, promastigotes must interact with extracellular matrix and basement membrane proteins (5) before infecting their cellular targets (3) . Promastigotes attach to fibrils of collagen I (6) and interact with collagen IV, fibronectin (FN), and laminin (5, 7) . A 67-kDa laminin binding protein, proposed to be an integral transmembrane protein, has been identified at the surface of Leishmania donovani promastigotes (8) . Leishmania also induces extracellular matrix remodeling. Indeed, fibronectin and collagen IV are degraded by the metalloprotease gp63, located at the surface of the parasites, which enhances their migration through the extracellular matrix (5) . Leishmania donovani promastigotes express on their surface proteins that are able to bind heparin (9) , which enhances their binding to macrophages (10) . Heparin is also involved in the interactions of Leishmania amazonensis amastigotes with macrophages (11) . All these studies have been performed with a few strains of Leishmania and a small number (1 to 3) of extracellular matrix molecules. The interplay of Leishmania parasites with the extracellular matrix of their mammalian hosts is thus poorly understood, although identification of the interactions established by Leishmania within the host extracellular matrix is a prerequisite for determining their roles in the infection process.
In order to identify the partners of Leishmania on a large scale, we performed binding assays with intact live Leishmania promastigotes by using protein and glycosaminoglycan arrays previously developed in our laboratory (12) (13) (14) . We investigated the ability of the logarithmic-phase promastigotes of 24 Leishmania strains and of the stationary-phase promastigotes of three of these strains to interact with ϳ70 molecules present in the skin, basement membrane, and blood vessels of their mammalian hosts. Six Leishmania species and four strains per species were selected to cover the three major forms of leishmaniasis: cutaneous, mucocutaneous, and visceral. Live Leishmania promastigotes were injected over the arrays in order to preserve their in vivo molecular recognition properties as much as possible. Their binding to host biomolecules spotted onto the arrays was detected simultaneously on all the spots of the arrays by surface plasmon resonance imaging (SPRi), which allows the detection of interactions in real time without labeling of the interactants. This is, to the best of our knowledge, the first comprehensive investigation of the interaction repertoires of Leishmania promastigotes with the extracellular matrix of their mammalian hosts. We report here the results of 54 binding experiments with protein and glycosaminoglycan arrays. Each experiment monitored simultaneously, in triplicate, 70 interactions between the host biomolecules and Leishmania promastigotes.
MATERIALS AND METHODS

Parasites.
The Leishmania parasites used in this study were selected and provided by the French National Reference Center of Leishmaniasis (CNRL). Promastigotes from 24 strains belonging to six Leishmania species with visceral (L. infantum, L. donovani), cutaneous (L. guyanensis, L. tropica, L. major), and mucocutaneous (L. braziliensis) tropism were tested in binding assays (see Table S1 in the supplemental material). It should be noted that although L. braziliensis is able to induce mucocutaneous lesions, the strains investigated in this study were isolated from cutaneous lesions.
Culture of Leishmania promastigotes. Previous studies on the interactions established by Leishmania with some extracellular matrix components were performed with various forms of the parasites, such as amastigotes (11), promastigotes near or at the stationary phase (15, 16) , stationary-phase promastigotes (5) and promastigotes fixed with 1% paraformaldehyde (17) . We used live, non-chemically-fixed promastigotes for surface plasmon resonance imaging (SPRi) binding assays in order to preserve their in vivo molecular recognition properties as much as possible. Binding assays were performed with promastigotes near the end of the logarithmic phase (procyclic form) or at the stationary phase (enriched in the metacyclic form). Promastigotes were first cultured in semisolid Novy-MacNeal-Nicolle (NNN) medium made of 90 ml of a liquid sterile agar salt (BD Difco Agar; catalog no. 214530) supplemented with 10 ml of fresh decomplemented rabbit blood (Charles River, France) and 125,000 U of penicillin G. Promastigotes grown in NNN medium (1 ml of a suspension of ϳ10 5 parasites/ml) were then transferred to 4 ml of Schneider's Drosophila medium (SDM; GIBCO BRL Life Technologies, USA) for visceral and mucocutaneous species or to 4 ml of RPMI 1640 medium (GIBCO BRL Life Technologies, USA) for cutaneous species. Both media were supplemented with 20% heat-inactivated fetal bovine serum (FBS; GIBCO BRL Life Technologies, USA) and 2% (vol/vol) filtered human urine obtained from an apparently healthy donor. The ventilated culture flasks (BD Falcon 12.5-cm 2 cell culture flasks; BD Biosciences, USA) were kept in darkness under agitation at 26°C. We selected the experimental conditions appropriate for obtaining a number of viable parasites sufficient for at least two consecutive SPRi experiments for all the Leishmania strains studied.
Protein and glycosaminoglycan arrays. The list of full-length proteins and their fragments, proteoglycans, glycosaminoglycans, growth factors, receptor ectodomains, and other proteins used for the binding assays is available as Table S2 in the supplemental material. Recombinant human tropoelastin isoform SHELdelta26A (synthetic human elastin without domain 26A), corresponding to amino acid residues 27 to 724 of GenBank entry AAC98394 (gi 182020), was purified from bacteria as described previously (18, 19) . Since elastin is insoluble, we used its soluble precursor, tropoelastin, as an elastin surrogate. von Willebrand factor domain 1 (the vWF1 domain) and the vWF2 and vWF3 (vWF2-3) domains of the human collagen ␣1 (VI) chain, endostatin, and the trimeric C-terminal domain (NC1) of collagen XVIII and its mutants were expressed in human embryonic kidney cells expressing Epstein-Barr virus nuclear antigen (293-EBNA cells) as described previously (20, 21) . Other biomolecules are from the commercial sources given in Table S2 in the supplemental material. The biomolecules were spotted in triplicate onto the gold surfaces of Gold affinity chips (GE Healthcare) at concentrations ranging from 60 to 1,000 g/ml for proteins and from 0.5 to 1 mg/ml for glycosaminoglycans with a noncontact spotter (sciFlexarrayer S3; Scienion, Germany). Eight drops of 330 pl each were delivered to the surface of the array (total volume spotted, 2.64 nl; total amount spotted, 0.144 to 2.64 ng/spot), yielding spots of ϳ250 to 300 m in diameter. The arrays, comprising 272 spots (17 ϫ 16), were then dried at room temperature and were stored under a vacuum at 4°C until use.
Commercially available tumor endothelial marker 8 (TEM8) was expressed with a glutathione S-transferase (GST) tag. To evaluate the nonspecific binding of Leishmania promastigotes to GST, we spotted both GST-tagged TEM8 and GST alone onto the arrays. Experiments were performed twice for one strain of each tropism (L. major LEM 2462, L. braziliensis LEM 2585, and L. infantum LEM 4705). A significant level of binding of these Leishmania strains to GST-tagged TEM8 was observed after the signal resulting from binding to GST was subtracted from the signal obtained with GST-tagged TEM8 (see Fig. S1 in the supplemental material). The interaction was thus considered significant for all the strains that bound to GST-tagged TEM8.
Identification of Leishmania partners by SPRi. Live Leishmania promastigotes were injected in buffer flow over protein and glycosaminoglycan arrays inserted into a Biacore Flexchip system (GE Healthcare, Sweden; Facility of UMS 3444/US8, Lyon, France) capable of monitoring as many as 400 interactions simultaneously by surface plasmon resonance imaging (22) . The regions of interest (ROIs) of the arrays were defined when the chip was dry. Each ROI had four associated reference spots that were used to correct bulk refractive index changes as well as nonspecific binding of Leishmania to the array surface. The arrays were blocked five times with a buffer containing mammalian proteins recommended by the manufacturer (Flexchip blocking buffer; GE Healthcare), with a 5-min pause between injections. The arrays were then equilibrated with phosphate-buffered saline (PBS)-0.05% Tween 20 (P3563; Sigma, France) at 150 l/min for 60 min. The parasites were diluted in PBS-0.05% Tween 20 to 40 ϫ 10 6 parasites/ml and were recirculated at the same flow rate over the array for 120 min at 25°C. The spontaneous dissociation of the complexes formed by Leishmania with the biomolecules spotted onto the array was monitored for 60 min in PBS-0.05% Tween 20. The data collected from the reference spots (bare gold) and/or from buffer spots were subtracted from those collected on spotted biomolecules in order to obtain the specific binding level. Since the blocking step was performed after spotting, the possible nonspecific binding of Leishmania promastigotes to the mammalian proteins of the blocking buffer was subtracted from the raw data by the procedure described above. Only interactions confirmed by at least two independent SPRi experiments for each Leishmania strain were considered for the analysis, except for one strain of L. braziliensis for which only one experiment was interpreted due to technical problems. The strength of binding events is reflected by their affinity, i.e., by the calculation of the equilibrium dissociation constant (K D ). However, the calculation of this parameter from SPRi data would require knowledge of the molecular mass of intact promastigotes, which is unknown. Furthermore, the SPRi system (Biacore Flexchip) used in this study has been designed mostly for screening purposes (yes/no answers) and not for the calculation of kinetics and affinity.
In vitro digestion of purified extracellular matrix proteins by logphase Leishmania promastigotes. Live Leishmania procyclic promastigotes (L. infantum, MHOM/FR/97/LEM3352; L. tropica, MHOM/MA/90/ LEM2023; and L. guyanensis, MHOM/GF/2003/LEM4570) were washed twice with 0.9% sodium chloride. A total of 5 ϫ 10 6 parasites were incubated in a 24-well plate with 10 g of human recombinant tropoelastin or human fibronectin (F2006; Sigma), with or without 5 mM or 15 mM 1,10-phenanthroline, at 37°C for 2 h, 4 h, or overnight. Leishmania parasites, tropoelastin, and fibronectin were also incubated alone, with or without 1,10-phenanthroline, as controls. At the end of the incubation period, the parasites were removed by centrifugation at 800 ϫ g for 5 min, and the supernatants were analyzed by SDS-PAGE followed by Coomassie blue staining (Thermo Scientific).
BLAST analysis. We performed BLASTP (Basic Local Alignment Search Tool) analyses (http://blast.ncbi.nlm.nih.gov/) (23) to determine if the sequences of the mammalian host proteins (UniProt release 2012_07, 11 July 2012) that interact with Leishmania promastigotes display similarities with proteins of the insect vector genera Phlebotomus and Lutzomyia. The sequences of the Leishmania partners were blasted against the proteomes of Lutzomyia (TaxID 7199; 1,996 sequences; NCBI) and Phlebotomus (TaxID 13203; 1,638 sequences; NCBI).
Leishmania-extracellular matrix interaction network. The interaction network of stationary-phase promastigotes with the extracellular matrix was visualized with Cytoscape, version 2.8.1 (http://www.cytoscape .org/) (24) . Network Analyzer (a Cytoscape plug-in) was used to calculate the numbers of interactions (degrees) of Leishmania partners in the extracellular interaction network built with MatrixDB (http://matrixdb .ibcp.fr/), the extracellular matrix interaction database developed in our laboratory (25) , after the removal of autolinks. Biomolecules with at least 10 partners were defined as hubs. MultiColoredNodes, version 2.5 (a Cytoscape plug-in), was used to color-code the biomolecules according to the Leishmania species with which they interact.
RESULTS
Design of the assay used to study the interactions of live Leishmania with the host. Experiments were carried out with live promastigotes in order to preserve the molecular recognition properties of proteins and/or glycoconjugates located at their surface and to mimic the in vivo situation as much as possible. Preliminary experiments were performed with variable numbers of parasites (4 ϫ 10 6 to 40 ϫ 10 6 parasites/ml), flow rates (100 to 250 l/min), and recirculation times of the parasites over the arrays. The criteria used to select the experimental conditions of Leishmania injection over the arrays were as follows: the binding level of Leishmania promastigotes to molecules spotted on the array must be higher than 10 resonance units after the subtraction of nonspecific binding to control spots, and the parasites must be intact after recirculation over the arrays. It was indeed mandatory to avoid parasite death and the associated release of intracellular molecules. We selected the lowest flow rate, and the shortest recirculation time, which gave the highest signal-to-noise ratio. This was obtained when 40 ϫ 10 6 parasites/ml were recirculated for 2 h at 150 l/min over the arrays at 25°C. The parasites collected after recirculation for 2 h appeared to be intact (see Fig. S2 in the supplemental material).
Twenty-four strains of logarithmic-phase Leishmania promastigotes and three strains of stationary-phase promastigotes were injected over arrays comprising ϳ70 host molecules (full-length proteins, domains, glycosaminoglycans, and selectively desulfated heparins [see Table S2 in the supplemental material]). The interactions between the parasites and host biomolecules were detected by SPRi. Each of the 24 strains was analyzed in at least two independent SPRi experiments, except for one strain of procyclic L. braziliensis where only the results of a single experiment were available due to technical problems. The interactions discussed below were observed on three different spots in at least two SPRi experiments. Other binding events were not considered reliable and were discarded.
As shown in Fig. 1A , SPRi experiments include an association phase, where Leishmania parasites are injected, are recirculated over the array, and form complexes with spotted biomolecules, and a dissociation phase, which starts when the recirculation of Leishmania is turned off after 2 h and Leishmania parasites are replaced by buffer. This phase reflects the dissociation of the complexes formed by the parasites with the biomolecules spotted onto the arrays. Since the SPRi signal is related to the mass of the injected sample, the decrease in signal level reflects the loss of mass due to the fact that Leishmania parasites are washed away from the array during their dissociation from the biomolecules spotted onto the arrays. The slope of the decreasing signal depends on the stability of the complexes.
Identification of host glycosaminoglycans binding to logarithmic-phase Leishmania promastigotes. Most of the Leishmania strains tested (83.3%) bound to high-molecular-weight heparin (Fig. 1A) and to heparan sulfate extracted from porcine intestinal mucosa (62.5%) ( Table 1 ). Only 12.5% of the strains tested bound to low-molecular weight heparin ( Table 1 ). The four strains of two cutaneous species (L. tropica and L. guyanensis) bound both to heparin and to heparan sulfate, but the third cutaneous species tested (L. major) displayed a different binding pattern (Table 1 ). The amount of Leishmania parasites that bound to heparan sulfate was decreased by 30% to 85% compared to the amount bound to heparin (data not shown), and none of the promastigotes tested bound to heparan sulfate from bovine kidney (see Table S3 in the supplemental material). This was likely due to differences in the sulfation pattern of heparan sulfate (26) . The role of sulfation was further investigated in SPRi experiments performed with selectively desulfated heparins (Fig. 2) . Most Leishmania strains bound to desulfated heparins to a lesser extent than to fully sulfated heparin (Table 1) . We normalized the binding level of Leishmania strains to heparin to 100% and calculated the residual binding to desulfated heparins (Fig. 2) . The binding of Leishmania strains to 6-O-desulfated heparin was decreased by at least 69% for all the species and by 89% for L. tropica (Fig. 2) . The removal of 2-O-sulfate groups inhibited the binding of L. donovani to heparin by 72% and of L. tropica by 46% (Fig. 2) , whereas the removal of N-sulfate groups inhibited the binding of L. tropica by 57% and abolished the binding of L. major to heparin (Fig. 2) . The binding of Leishmania promastigotes to N-desulfated and re-N-acetylated heparin was inhibited by 24% to 100% depending on the species (Fig. 2) . Nearly half of the Leishmania strains interacted with high-molecular-weight hyaluronan and a smaller proportion (37.5%) interacted with low-molecular-weight hyaluronan (M w , 25,000 to 75,000) ( Table 1) . Only the New World species L. braziliensis and L. guyanensis bound to chondroitin sulfate (CS) or dermatan sulfate (DS) ( Table 1 ), but this binding was restricted to a single Leishmania strain in both species. Binding to glycosaminoglycans did not appear to be specific to a particular tissue tropism, except for low-molecular-weight heparin, which bound only to Leishmania strains with cutaneous tropism, but the binding was restricted to one strain of each species (Table 1) .
Identification of host proteins and proteoglycans interacting with logarithmic-phase Leishmania promastigotes. The proteins and protein fragments that did not bind to any procyclic promastigote as determined by SPRi are listed in Table S3 in the supplemental material. Plasminogen was spotted onto the arrays as a positive control because it has been reported previously to bind to Leishmania (27) . Indeed, all Leishmania strains tested in this study bound to plasminogen ( Fig. 1B; Table 2 ). Besides plasminogen, the ectodomain of tumor endothelial marker 8 (TEM8), upregulated in the vasculature during angiogenesis (28) , and tropoelastin bound to all the species tested ( Table 2) . Very frequent binders, defined as proteins interacting with more than 75% of the Leishmania strains tested, included several angiogenesis regula-tors, such as the extracellular matrix protein 1 (ECM-1 protein; binding to 87.5% of Leishmania strains tested) ( Fig. 1C; Table 2 ), the vascular endothelial growth factor (VEGF) (Fig. 1D) , and two matricryptins with antiangiogenic properties, anastellin, derived from fibronectin (91.7%) ( Fig. 1E ; Table 2 ), and endostatin, a matricryptin of collagen XVIII (29) (Fig. 1F ; Table 3 ). The binding of endostatin to Leishmania parsites was transient compared to that of the other angiogenesis regulators, as shown by the slope of the dissociation phases in SPRi experiments (Fig. 1C to G) .
Among the frequent partners (those bound to 26 to 75% of the Leishmania strains tested) were the ␤-amyloid peptide (1-42) and brevican (Table 2) , both found in the brain. Collagens I, II, V, and VI were also frequent partners of Leishmania parasites, except for the visceral species. Indeed, L. donovani did not interact with collagens. The binding of promastigotes to collagen VI was not mediated by the von Willebrand factor domains of the ␣1 chain of collagen VI, since von Willebrand domain 1 and domains 2-3 of this chain did not interact with Leishmania parasites (see Table S3 in the supplemental material). The role of the triple helix in the binding of promastigotes to collagens was dependent on the strains. Some Leishmania strains lost their ability to bind to collagens upon denaturation, whereas some gained binding and interacted with denatured, but not with native, collagen ( Table 2 ). The L. major and L. braziliensis strains bound to the native, triplehelical form of collagen II. The triple helix was also required for the binding of one strain of L. major, which did not bind to dena- tured collagen II. In contrast, most L. braziliensis strains did not interact with native collagens III and VI but only with their heatdenatured forms. Occasional partners, interacting with 10 to 25% of the Leishmania strains tested, included ␤2-microglobulin, denatured collagens II and III, neuroglycan, transglutaminase-2 (TGase-2), tropomyosin, and vitronectin (Table 2) . Very occasional binders, interacting with Ͻ10% of the Leishmania strains tested, were collagens III and IV, the C-terminal trimeric domain of collagen XVIII, thrombospondin-1 (TSP-1), and the ectodomains of syndecan-2 and glypican-2 ( Table 2) .
The vast majority of the proteoglycans tested in this study (perlecan, neurocan, aggrecan, and the small leucine-rich proteoglycans decorin, fibromodulin, lumican, and biglycan) did not bind to Leishmania parasites (see Table S3 in the supplemental material). In contrast, brevican bound to 33% of Leishmania strains (100% of L. tropica strains and 75% of L. donovani strains [ Table 2 ]), and L. braziliensis was the only species to interact with the ectodomain of both syndecan-2 and neuroglycan ( Table 2) .
None of the strains studied bound to the ectodomains of ␣v␤3, ␣5␤1, ␣v␤5, and ␣4␤1 integrins, VEGFR-2, syndecans 1, 3, and 4, or glypicans 1, 3, 5, and 6 (see Table S3 ). However, only the ectodomains of these receptors or coreceptors were spotted onto the arrays used for binding assays, and we cannot exclude the possibility that the parasites might bind to full-length receptors or coreceptors.
The interaction repertoires of the six Leishmania species, ranked according to the percentages of strains that bind to host molecules, are displayed in Fig. 3 . The specific features of tissue tropism are listed on the right in Fig. 3 . L. braziliensis has a larger interaction repertoire (26 partners) than the other Leishmania species (15 to 24 partners).
Leishmania partners identified by SPRi belong to the mammalian host. Mammalian (mostly human) proteins were used for SPRi binding assays with intact promastigotes. To determine if the Leishmania partners identified in these experiments were restricted to their mammalian hosts or were also present in the in- sect hosts, we looked for similar sequences in the proteomes of the insect vectors Phlebotomus and Lutzomyia. Only a few significant matches (E value, Ͻ0.01) were found. Sixteen protein sequences of the genus Phlebotomus and 11 sequences of the Lutzomyia, corresponding to serine proteases (trypsin and chymotrypsin enzymes), contained a sequence homologous to the peptidase S1 domain of human plasminogen. Eight Lutzomyia proteins (Ctype lectin and ϳ16-kDa salivary proteins) contained a sequence similar to the C-lectin domain of brevican. However, it is unlikely that this domain contributes significantly to the binding of brevican to Leishmania parasites, because two other proteoglycans (neurocan and aggrecan) containing this domain failed to interact with promastigotes in SPRi experiments (see Table S3 in the supplemental material). These results suggest that most, if not all, Leishmania interactions identified in this study correspond to those established with the mammalian host and not with the insect vector of Leishmania.
Procyclic Leishmania promastigotes are able to degrade human tropoelastin. SPRi experiments showed that the procyclic promastigotes of all the species tested bound to human tropoelastin ( Fig. 4A; Table 2 ). A strong decrease in the SPR signal was observed ϳ15 min after the injection, during the recirculation (association phase) of several Leishmania species over the arrays, suggesting that the parasites might degrade tropoelastin spotted onto the arrays (Fig. 4B) tions. No band was detected when Leishmania was incubated without tropoelastin (data not shown), and tropoelastin alone was not cleaved when incubated without Leishmania (Fig. 5) . A faint band migrating faster than tropoelastin (53 kDa versus 60 kDa) was observed after 2 h and 4 h of incubation with L. tropica, indicating that tropoelastin was cleaved by the parasites (Fig. 5A ). The same cleavage product was observed after the incubation of tropoelastin with L. guyanensis for 2 h, and this product was further digested after 4 h of incubation (Fig. 5B ). We were unable to determine the sequence of the 53-kDa degradation product of tropoelastin by tandem mass spectrometry (MS-MS) after in-gel digestion, but it clearly differs from the serine protease hypersensitive site at R515, which would have given a 45-kDa product (30) . Tropoelastin was no longer detected when it was incubated for 2 h with L. infantum, suggesting that this species is able to cleave tropoelastin into peptides too small to be detected under our experimental conditions (Fig. 5C) . Some experiments were carried out in the presence of 1,10-phenanthroline, a zinc chelator, to determine whether the Leishmania enzyme(s) responsible for the cleavage was a zinc metalloprotease such as gp63, the major surface protease of Leishmania. Several concentrations of 1,10-phenanthroline were tested, up to 15 mM, the limit of solubility in aqueous solutions. There was no inhibition of tropoelastin cleavage by L. infantum or L. tropica in the presence of 15 mM 1,10-phenanthroline, indicating that the cleavage of tropoelastin by these Leishmania species was not catalyzed by the zinc-dependent metalloprotease gp63, which cleaves collagen type IV and fibronectin (5) . The cleavage of tropoelastin by L. guyanensis was partially inhibited when digestion was carried out for 2 h in the presence of 15 mM 1,10-phenanthroline (Fig. 5B) , suggesting that other proteases contribute to tropoelastin degradation by this Leishmania strain. Since fibronectin has been reported to be digested by intact Leishmania parasites (5), we used it as a positive control to assess the proteolytic activity of the promastigotes. Fibronectin incubated with L. tropica or L. infantum was digested, and the digestion was partially inhibited by 1,10-phenanthroline in a concentration-dependent manner (see Fig. S3 in the supplemental material). Collagen IV was also degraded by Leishmania parasites (data not shown), as reported previously (5) . Identification of host biomolecules binding to stationaryphase Leishmania promastigotes. The poor survival of some strains in the stationary phase did not allow us to perform two consecutive SPRi binding assays for the 24 strains of Leishmania.
Thus, we selected one strain representative of each tropism (L. major LEM 2462, L. braziliensis LEM 2585, and L. infantum LEM 4705) in order to identify the partners of promastigotes enriched in the metacyclic form and to compare them with those of procyclic promastigotes (Table 4) .
L. major promastigotes bound to chondroitin sulfate, whereas L. braziliensis and L. infantum bound to dermatan sulfate (Table  4 ). All the stationary-phase promastigotes bound to heparin and heparan sulfate extracted from porcine intestinal mucosa (Table  4 ). The three strains retained their ability to bind to 2-O-desulfated heparin (Fig. 6) , showing that 2-O-sulfate groups do not contribute to Leishmania binding. In contrast, the removal of 6-O-sulfate and N-sulfate groups inhibited the binding of L. braziliensis and L. infantum to heparin by at least 70% and 50%, respectively, and abolished the binding of L. major to heparin (Fig. 6) .
All the stationary-phase promastigotes tested bound to plasminogen, the ectodomain of TEM8, VEGF, the ECM-1 protein, ␤-amyloid peptide (1-42), collagen II, and the NC1 domain of collagen XVIII ( Fig. 7A ; Table 4 ). In contrast, only L. infantum promastigotes bound to tropoelastin (Table 4) , although, based on the SPR signal, they did not seem to be able to cleave it. Furthermore, stationary-phase promastigotes of L. braziliensis bound to fibronectin and to laminin-111, whereas their procyclic forms did not (Table 4) .
Host-Leishmania interaction network. In order to determine the importance of the partners of Leishmania promastigotes enriched in metacyclic forms, we calculated their degrees (i.e., the numbers of interactions they establish) in the extracellular interaction network. Almost half (47%) of the molecules tested in SPRi experiments (molecules spotted onto the arrays) had at least 10 partners in the extracellular interaction network and were thus considered hubs (Fig. 7B ), compared to 63% of the partners of Leishmania parasites (Fig. 7C) , showing that Leishmania parasites preferentially target extracellular hubs. Among these hubs, eight (six proteins and two glycosaminoglycans) interacted with all the stationary-phase Leishmania species, whereas three (fibronectin, thrombospondin-1, and brevican) bound only to L. braziliensis and two (tropoelastin and collagen III) bound only to L. infantum. There was no hub specifically interacting with L. major (Fig. 7D) .
Effect of antiangiogenic factors on Leishmania growth. Endostatin and anastellin, two antiangiogenic matricryptins, interact with most Leishmania promastigotes. Since antileishmanial drugs such as fumagillin and artemisinin derivatives exhibit antiangiogenic properties (31, 32), we investigated the ability of endostatin and anastellin to inhibit Leishmania growth by an assay that has been used previously to test the effects of several drugs on Leishmania growth (32) . Briefly, the amount of live Leishmania cells was determined after 48 h of treatment with different concentrations of anastellin and endostatin. Pentamidine was used as a positive control. The assays performed in the absence of any drug (0 M both for pentamidine and anastellin) were used as negative, untreated controls (see Fig. S4 and S5 in the supplemental material). Neither anastellin nor endostatin inhibited the growth of L. tropica, whereas pentamidine, used as a positive control, inhibited the growth of L. tropica with a 50% inhibitory concentration (IC 50 ) of 2.7 M, in agreement with the values previously calculated by others for L. donovani (3.5 M [31] and 1.69 M [32] ) (see Fig. S4 and S5 ). Our data show that although the well-known antileishmanial drug pentamidine is antiangiogenic, antiangio- genic molecules do not necessarily have antileishmanial properties. Fumagillin, which inhibits a metalloprotease, the methionine aminopeptidase-2 (32), inhibits parasite growth, whereas endostatin and anastellin, both of which target integrin receptors regulating angiogenesis (33), do not inhibit the growth of Leishmania. This suggests that the mechanisms of action of antiangiogenic molecules are important in defining their ability, or inability, to inhibit the growth of the parasite.
DISCUSSION
In this study, we have identified and analyzed the interaction networks of intact Leishmania promastigotes with the extracellular matrix of their mammalian hosts by using protein and glycosaminoglycan arrays. This is, to the best of our knowledge, the first large-scale study to identify binding partners of live Leishmania parasites. Indeed, most binding studies performed so far have been performed with only one strain of Leishmania and few host molecules (5, 6) . Promastigotes were not fixed with paraformaldehyde before the SPRi assays, in contrast to those used for studying the interaction of L. braziliensis to Lulo cells or to a heparincoated surface by SPR (17, 34) .
All the Leishmania strains tested bind to TEM8 and plasminogen. We have identified, in total, 27 new partners (23 proteins, 4 
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a Binding (ϩ) was confirmed in two independent SPRi experiments for each strain. Ϫ, no binding; ND, not determined.
glycosaminoglycans) for six species of procyclic promastigotes and 18 new partners (15 proteins, 3 glycosaminoglycans) for three species of stationary-phase promastigotes enriched in metacyclic forms. Comparison of the numbers of partners of the three Leishmania strains investigated both as logarithmic-phase promastigotes and as promastigotes enriched in the metacyclic form shows that the stationary-phase promastigotes of L. braziliensis and L. infantum have higher numbers of partners than the logarithmicphase promastigotes (20 versus 13 and 16 versus 9, respectively). This suggests that the infective forms of both strains are able to establish more interactions with the host ECM. In contrast, L. major binds to more partners in the procyclic phase than in the stationary phase (14 versus 11) . It is, of course, difficult to draw firm conclusions from experiments performed on single strains of three species, but this difference might be due to the tropism and the associated difference in infectivity. In vitro metacyclogenesis of a visceral and a cutaneous human strain of Leishmania infantum has shown that the metacyclic promastigotes of the visceral strain showed a higher infective capability for macrophages and a higher resistance to lysis by complement than the metacyclic promastigotes of the cutaneous strain (35) . Changes induced in surface proteins by metacyclogenesis might affect those involved in ECM binding in a different way in L. major than in L. braziliensis and L. infantum. Leishmania promastigotes are deposited in the skin of their hosts by infected sand flies, and several Leishmania partners are found either in the dermal-epidermal junction (collagen IV, ECM-1 [36] , heparan sulfate) or in the dermis (e.g., hyaluronan and collagens I, V, and VI). Most Leishmania promastigotes assayed in this study interacted with heparin, a model compound for heparan sulfate, in agreement with previous reports (9, 17) . However, several Leishmania strains that bound to heparin did not bind to heparan sulfate. This might be due to differences in the structures of these glycosaminoglycans. Heparan sulfate is less sulfated than heparin, contains clustered sulfate groups organized in highly sulfated domains, and has a longer and more bent conformation than heparin (37) . It is thus not relevant to automatically infer from the experimentally proven ability of Leishmania parasites to bind heparin that they also bind to heparan sulfate and to heparan sulfate proteoglycans at the host cell surface and that these proteoglycans play a role in Leishmania adhesion to and/or entry into host cells. High-molecular-weight hyaluronan binds to 75% of L. donovani strains, in agreement with the overexpression of a hyaluronic-acid-binding protein in the spleen, liver, macrophages, and serum of hamsters infected with this parasite (38) .
Leishmania promastigotes interact with the regulators of angiogenesis. In addition to the antiangiogenic matricryptins endostatin and anastellin, most promastigotes bind to proangiogenic factors such as ECM-1 (36, 39), TEM8 (40) , and VEGF (41) . The promotion of angiogenesis might provide a favorable environment for Leishmania, since several antileishmanial molecules have antiangiogenic activity (31, 32) and since L. donovani promastigotes are able to synthesize their own basic fibroblast growth factor (FGF)-like molecules (42) . Furthermore, VEGF is upregulated by the hypoxia-inducible factor HIF-1, which is activated by L. donovani for its survival within host macrophages (43) . However, hypoxia might be downregulated at some time points during the course of Leishmania infection, since it has been reported to reduce the percentage of infected cells and the number of intracellular parasites in vitro (44) , and/or other factors might be involved. The antiangiogenic matricryptins, endostatin and anastellin, might be released from their parent molecules by host proteases to create an antiangiogenic environment as a defense mechanism against Leishmania infection.
TEM8, which is upregulated on angiogenic endothelial cells (40) and which bound to all the Leishmania strains tested, is also one of the receptors of the anthrax toxin (28) . Whether it plays a significant role in Leishmania adhesion to macrophages and in the parasite's entry into these cells remains to be determined. Since TEM8 shares 47% amino acid identity with capillary morphogenesis protein 2 (CMG2), another cell surface receptor of anthrax toxin, Leishmania promastigotes might also interact with CMG2, which is preferentially expressed over TEM8 in primary human and mouse macrophages (45) . Several collagens synthesized by macrophages (e.g., collagens II, III, and VI [46] ) bind to Leishmania promastigotes. These interactions may contribute not only to the interactions of Leishmania parasites with the skin extracellular matrix but also to their localization in the pericellular environment of macrophages. Collagen VI, one of the most abundant collagens expressed by human macrophages (46) , might play a specific role, because it interacts both with Leishmania promastigotes and with TEM8 (47) .
Procyclic promastigotes bind to tropoelastin, a major constituent of the dermis, and several Leishmania strains are able to cleave it. Elastic and elaunin fibers are preserved in murine models of leishmaniasis (48) , but this does not exclude local remodeling of the elastin network at the sites of parasite inoculation into the skin to ease their migration in the dermis. We failed to determine the sequences of tropoelastin fragments released by Leishmania parasites, although that information would be interesting, because elastin fragments exhibit potent chemotactic activity for leukocytes and have proangiogenic activity as potent as that of VEGF (49, 50) . The ␤-amyloid peptide and brevican, both found in the brain, bound to all the stationary-phase promastigotes tested and to most procyclic promastigotes. The ability of Leishmania strains to interact with molecules specifically expressed in the brain might be related to reported instances of central or peripheral neurologic manifestations during Leishmania infection both in humans and in animals (51) and to the detection of amastigotes in the central nervous systems of Leishmania-infected hamsters (52) . The presence of brain proteins in the interaction repertoire of Leishmania parasites might ease their interaction with the brain environment. L. braziliensis displays the largest interaction repertoire with membrane proteins, interacting with both neuroglycan and syndecan-2, which is synthesized by macrophages (53) , and might participate in Leishmania adhesion to macrophages in association with other receptors, such as TEM8, as described above.
The biological relevance of the interactions identified in this study might be assessed by investigating their effects on the infection of macrophages by Leishmania. This might be done, for example, for the Leishmania-TEM8 interaction by preincubating macrophages with an anti-TEM8 antibody and/or with one subunit of the anthrax toxin and by infecting them with metacyclic promastigotes in order to calculate the percentage of infected macrophages and the number of amastigotes in infected cells. In vivo experiments might also be performed by infecting TEM8-or endostatin-null mice and studying the outcome of the infection.
In conclusion, we have identified, in total, 27 new partners (23 proteins, 4 glycosaminoglycans) of six species of Leishmania procyclic promastigotes and 18 partners (15 proteins, 3 glycosaminoglycans) of three species of stationary-phase promastigotes for all the strains tested. All the Leishmania strains interact with TEM8 and plasminogen, and most Leishmania strains interact with regulators of angiogenesis, which might modulate the infection of macrophages by the parasites. Furthermore, the screening method based on arrays and SPRi might be used to characterize the interaction repertoires of other pathogens, with their extracellular targets.
